Literature DB >> 10203287

Irinotecan-induced central nervous system toxicity: a case report.

I Sevilla Garcia, A Rueda, E Alba.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203287     DOI: 10.1093/jnci/91.7.647

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases.

Authors:  Ayumu Matsuoka; Osamu Maeda; Megumi Inada-Inoue; Eizaburo Ohno; Yoshiki Hirooka; Yukihiro Yokoyama; Tsutomu Fujii; Masato Nagino; Hidemi Goto; Yuichi Ando
Journal:  Oncol Lett       Date:  2015-08-11       Impact factor: 2.967

2.  Irinotecan-induced dysarthria: an insight into its pathogenesis?

Authors:  Jesus A Gomez; Ines Sanchez; Jose A Ramirez
Journal:  Gastrointest Cancer Res       Date:  2008-07

Review 3.  FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity.

Authors:  Krishna S Gunturu; Xiaopan Yao; Xiangyu Cong; Jaykumar R Thumar; Howard S Hochster; Stacey M Stein; Jill Lacy
Journal:  Med Oncol       Date:  2012-12-28       Impact factor: 3.064

4.  Irinotecan-induced dysarthria.

Authors:  Albertine J Dressel; Johannes C van der Mijn; Ijke J Aalders; Rico N P M Rinkel; Hans J van der Vliet
Journal:  Case Rep Oncol       Date:  2012-01-18

5.  Irinotecan-Associated Dysarthria in Patients with Pancreatic Cancer: A Single Site Experience.

Authors:  Ali Elbeddini; Naushin Hooda; Mohamed Gazarin; Penny Webster; Jackie McMillan
Journal:  Am J Case Rep       Date:  2020-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.